Evidence map›Paper›PMID 42726849›Full record

ArticleScience advances2026

Ex vivo bone marrow subniches influence the fate of human antibody-secreting cells.

Liana Kramer, Zhonghao Dai, Jenna Corbin, Rachel Ringquist, Eshant Bhatia, Ingrid Petersen, Delta Ghoshal, Ritika Jain, Valeria M Juarez, Zhe Zhong and 5 more

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Liana KramerCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.ORCID 0000-0003-4493-1651
Zhonghao DaiCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.ORCID 0000-0002-2543-269X
Jenna CorbinCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.ORCID 0009-0009-0877-5007
Rachel RingquistSchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA, USA.ORCID 0009-0006-6112-8325
Eshant BhatiaWoodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.ORCID 0000-0002-4451-9889
Ingrid PetersenCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.ORCID 0009-0009-2527-348X
Delta GhoshalCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.ORCID 0000-0003-0492-0261
Ritika JainCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.ORCID 0000-0003-4530-7578
Valeria M JuarezCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.ORCID 0000-0002-8670-015X
Zhe ZhongWoodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.ORCID 0009-0001-8659-3040
Savi AgarwalCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.
F Eun-Hyung LeeDepartment of Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Emory University, Atlanta, GA, USA.ORCID 0000-0002-6133-5942
Steven GoudyCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.
Ankur SinghCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.ORCID 0000-0002-3501-2277
Krishnendu RoyCoulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.ORCID 0000-0002-9972-0950

Funding

T32 CTEng (Cellular and Tissue Engineering) Training ProgramT32GM145735 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI Edward A. Botchwey, Andres J Garcia · 2022 to 2026
$2.3M
Hydrogel-based lymphoid tissues for generation of activated human B cells and delivery in vivoR01AI186314 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI Ankur Singh · 2024 to 2026
$2.3M
Hydrogel-Based Aged Immune Organoids to Study Epigenetics and Trajectory of B CellsR01AI181282 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI Ankur Singh · 2024 to 2026
$2.2M
NIAID NIH HHS R01 AI181282NIAID NIH HHS R01 AI186314NIGMS NIH HHS T32 GM145735Wellcome Trust
6 · The paper itself

Abstract

Long-term humoral immunity relies on long-lived plasma cells in the bone marrow (BM). However, the processes governing plasma cell transport, positioning, and longevity within the BM niche remain poorly understood, especially in humans. Most existing knowledge comes from mouse studies or limited human-based models, which makes translating findings to human biology challenging. Here, we introduce a physiologically relevant human bone marrow-on-a-chip (hBMOC) model to investigate the behavior and interactions of human immune organoid-derived antibody-secreting cells (ASCs) within the human BM microenvironment. The hBMOC model is microvascular and perfusable and incorporates both endosteal and perivascular niches. We demonstrate that human ASCs migrate through blood vessels, accumulating and clustering in perivascular areas where they are closely associated with critical survival factors. In addition, we found that the presence of the endosteal niche substantially affects human ASC survival, movement, and retention, underscoring the dynamic interactions among human BM subniches that regulate ASC activity. We observed that a subset of human ASCs exhibits a dynamic stop-and-go migration pattern partially regulated by CXCR4-CXCL12 signaling. These findings provide direct insight into human ASC biology that has remained poorly defined, including their niche-specific localization, survival, and migratory dynamics within a three-dimensional human bone marrow microenvironment. Our results emphasize the distinct and cooperative roles of perivascular and endosteal compartments in supporting human ASC fate, offering previously inaccessible mechanistic insights into how human BM niches regulate plasma cells. This work lays the groundwork for studying plasma cell aging, vaccine durability, and disease-related dysfunction in human ASC maintenance and persistence.

Indexed as

Antibody-Producing CellsBone MarrowBone Marrow CellsCell MovementCellular MicroenvironmentChemokine CXCL12HumansMicrophysiological SystemsReceptors, CXCR4Signal TransductionChemokine CXCL12CXCR4 protein, humanReceptors, CXCR4

Identifiers

PMID42726849
PMCPMC13564807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.